Tech Company Financing Transactions

Proneuron Biotechnologies Funding Round

DFJ Tamir Fishman Ventures invested in a $18 million venture round for Proneuron Biotechnologies. The round was recorded on 7/11/2004.

Transaction Overview

Announced On
7/11/2004
Transaction Type
Venture Equity
Amount
$18,000,000
Round
Undisclosed
Investors
Proceeds Purpose

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
14 East 60th St. 403
New York, NY 10022
USA
Email Address
Not Recorded
Overview
Proneuron Biotechnologies, a Delaware company, is in advanced stages of clinical development in a number of attractive neurological markets.
Profile
Proneuron Biotechnologies LinkedIn Company Profile
Social Media
Proneuron Biotechnologies Company Twitter Account
Company News
Proneuron Biotechnologies News
Facebook
Proneuron Biotechnologies on Facebook
YouTube
Proneuron Biotechnologies on YouTube

Management Team

Title
Name
Email & Social
Chairman
Dale Miller
  Dale Miller LinkedIn Profile  Dale Miller Twitter Account  Dale Miller News  Dale Miller on Facebook
Founder
Michal Schwartz
  Michal Schwartz LinkedIn Profile  Michal Schwartz Twitter Account  Michal Schwartz News  Michal Schwartz on Facebook
VP - Finance
Jeremy Rome
  Jeremy Rome LinkedIn Profile  Jeremy Rome Twitter Account  Jeremy Rome News  Jeremy Rome on Facebook
VP - R & D
Eti Yoles
  Eti Yoles LinkedIn Profile  Eti Yoles Twitter Account  Eti Yoles News  Eti Yoles on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/9/2004: Alimera Sciences venture capital transaction
Next: 7/12/2004: Icera Semiconductor venture capital transaction

 

Share this article

 


About Database of VC Transactions

We report on funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary